Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Observational Study on Anti-interleukin-1 Receptor Antagonist Antibodies and Soluble Urokinase Plasminogen Activator Receptor (suPAR) in Pericarditis: PERIPLO (PERicarditis: IL-1 RA Antibodies and suPAR Levels Observational) Study

NCT05925790 is registered in ClinicalTrials.gov with ASST Fatebenefratelli Sacco as lead sponsor.

NCT NCT05925790
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05925790 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Observational Study on Anti-interleukin-1 Receptor Antagonist Antibodies and Soluble Urokinase Plasminogen Activator Receptor (suPAR) in Pericarditis: PERIPLO (PERicarditis: IL-1 RA Antibodies and suPAR Levels Observational) Study
Lead sponsor
ASST Fatebenefratelli Sacco
Phase
Observational
Overall status
Unknown status
Start date
July 1, 2023
Completion date
December 20, 2025
Enrollment
146 (estimated)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

pericarditis